C12Y 207/01153
Phosphatidylinositol-4,5-bisphosphate 3-kinase , i.e. phosphoinositide 3-kinase
Official title: Phosphatidylinositol-4,5-bisphosphate 3-kinase (2.7.1.153), i.e. phosphoinositide 3-kinase
C12Y207/01153 (Phosphatidylinositol-4,5-bisphosphate 3-kinase , i.e. phosphoinositide 3-kinase) appears on 5 US grants and 20 published applications in this corpus.
Search patents in C12Y- Granted patents
- 5
- Published applications
- 20
- Assignees
- 13
- Inventors
- 40
- Latest grant
- 9 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 2 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 2 |
| 2018 | 1 | 1 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 2 |
| 2023 | 0 | 2 |
| 2024 | 1 | 2 |
| 2025 | 2 | 0 |
| 2026 | 0 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- T cell receptors targeting PIK3CA mutations and uses thereof9 Dec 2025US 12,492,237 B2Memorial Sloan Kettering Cancer Center
- Neoantigen peptide mimics15 Apr 2025US 12,275,766 B2Janssen Biotech, Inc.
- Methods and pharmaceutical compositions for treating lymphoid malignancy30 Apr 2024US 11,969,428 B2
- PIK3CA novel mutations detection for diagnosis of acquired cetuximab resistance in metastatic colorectal cancer patients30 Jun 2020US 10,697,022 B2Affiliated Hospital, Academy of Military Medical Sciences
- Therapeutics with conformationally restricted monomers17 Jul 2018US 10,023,863 B2Marina Biotech, Inc.
- Compositions and methods for generating porcine ovarian tumor model6 Aug 2026US 2026/0223823 A1Georgia Tech Research Corporation
- T cell receptors targeting pik3ca mutations and uses thereof21 May 2026US 2026/0139026 A1Memorial Sloan Kettering Cancer Center
- Use Of P55gamma As Therapeutic Target For Aortic Dissection (ad)2 Apr 2026US 2026/0091091 A1Beijing Friendship Hospital, Capital Medical University
- Methods and pharmaceutical compositions for treating lymphoid malignancy31 Oct 2024US 2024/0358708 A1
- Compositions and methods of treating a pi3k mediated disease7 Mar 2024US 2024/0075093 A1Virginia Tech Intellectual Properties, Inc.
Most cited
By later US patents